Received Jun 27, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RAB | RABIES (RABAVERT) | NOVARTIS VACCINES AND DIAGNOSTICS | 1 | Unknown | — |
Patient received day zero dose of RabAvert and was supposed to receive the day seven dose but cant get it; Case reference number US-BN-2024-002110 is a spontaneous case initially received from a pharmacist via Med Communications (reference number: USBAV24-1497) on 26-Jun-2024 and concerns an adult female patient. The patient's medical history and concomitant medication were not provided. On an unspecified date, reported as day zero, the patient was vaccinated with the first dose of RabAvert (batch number: unknown), at an unknown dose, route or site of administration for pre-exposure. As reported patient received day zero dose and was supposed to receive the day seven dose but could not get it (explicitly coded as 'inappropriate schedule of vaccine administered'). At the time of the initial report, it was unknown if the patient experienced any adverse event due to RabAvert. Additional information received from Med Communications on 02-Jul-2024 included missing description from the initial source form.; Reporter's Comments: An adult female patient was vaccinated with the first dose of RabAvert for pre-exposure. As reported the patient received day zero dose and was supposed to receive the day seven dose but could not get it, which is considered as inappropriate schedule of vaccine administered. It was unknown if the patient experienced any adverse event due to RabAvert. Inappropriate schedule of product administration is considered as listed per company convention. The patient's medical history and concomitant medication were not provided. Inappropriate schedule of product administration has been considered as not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: An adult female patient was vaccinated with the first dose of RabAvert for pre-exposure. As reported the patient received day zero dose and was supposed to receive the day seven dose but could not get it, which is considered as inappropriate schedule of vaccine administered. It was unknown if the patient experienced any adverse event due to RabAvert. Inappropriate schedule of product administration is considered as listed per company convention. The patient's medical history and concomitant medication were not provided. Inappropriate schedule of product administration has been considered as not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.
Comments: None.